Ivy and neurogliaform interneurons are a major target of μ-opioid receptor modulation

Esther Krook-Magnuson1, Lillian Luu, Sang-Hun Lee

  • 1Department of Anatomy and Neurobiology, University of California, Irvine, California 92697-1280, USA. ekrookma@uci.edu

Insights

The study identifies neurogliaform cells as a new target for micro-opioid receptors (microORs) in the hippocampus. MicroOR activation hyperpolarizes these cells and inhibits their synaptic output, impacting brain circuitry.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Pharmacology

Background:

  • Micro-opioid receptors (microORs) are known to modulate interneurons in the hippocampus.
  • While fast-spiking parvalbumin basket cells express microORs, another major GABAergic cell class modulated by microORs remained unidentified.

Purpose of the Study:

  • To identify the previously unrecognized GABAergic cell class modulated by microORs in hippocampal area CA1.
  • To investigate the direct effects of microOR activation on the properties and synaptic function of neurogliaform cells.

Main Methods:

  • Utilized a mouse line with green fluorescent protein under the neuropeptide Y promoter for cell identification.
  • Performed paired recordings between synaptically coupled Ivy and pyramidal cells.
  • Assessed the effects of microOR agonist on Ivy and neurogliaform cell membrane potential and firing properties.

Main Results:

  • Neurogliaform family cells (Ivy and neurogliaform cells) were identified as a novel target of direct microOR modulation.
  • MicroOR activation led to hyperpolarization of Ivy and neurogliaform cells across all CA1 layers.
  • MicroOR activation significantly inhibited Ivy cell synaptic terminals and suppressed the induction of persistent firing in Ivy cells.

Conclusions:

  • Neurogliaform cells represent a major, previously unrecognized target of microOR modulation in the hippocampus.
  • Opioid modulation of neurogliaform cells has broad implications for hippocampal microcircuitry and function.
  • These findings expand our understanding of opioid receptor signaling in the central nervous system.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...